GSK boss Emma Walmsley’s pay could rise to nearly £22m in three years’ time UK pharmaceutical companies aim to put executive pay on par with US rivals’ but package will depend on share price The Guardian - UK · Feb 27, 2025
Women hold almost 45% of seats on FTSE 100 boards, report says New high tempered by dip in number of female CEOs at 100 biggest listed firms to fewer than 10 last year The Guardian - UK · Feb 25, 2025
AstraZeneca, Whitehall, and a failed £450m deal for the next generation in vaccines. What went wrong? When the pharma firm cancelled plans for a major expansion of its Merseyside plant last month, there was no shortage of questions – or blame – over responsibility The Guardian - UK · Feb 8, 2025
Despite Profit Fallout, GSK Remains Optimist For 2031 Revenue Target Amidst Cancer Drug Sale Rise GSK's oncology sales increased 98% in 2024, and reflects strong demand and potentially new launches or indications for cancer therapies. International Business Times UK · Feb 7, 2025
Drug firm GSK delivers a syringe full of crowd-pleasers Pharmaceuticals company’s higher dividend, upgrade to revenues and share buyback suggest its drugs pipeline is flowing nicely The Guardian - UK · Feb 5, 2025
Novo Nordisk confident despite Trump tariff risk as sales of weight-loss jab soar Europe’s biggest firm, whose sales of Wegovy almost doubled, feels it can ‘meet demands’ of US administration The Guardian - UK · Feb 5, 2025
GSK lifts long-term sales targets on new drug pipeline It came as the boss of the London-listed firm cheered an ‘excellent’ performance in 2024. Evening Standard · Feb 5, 2025
The ‘super powerful’ tool behind a pharmaceutical giant’s global regulatory operation When GSK’s regulatory teams needed help to sharpen up their project management, they turned to Smartsheet to reduce admin, increase collaboration and enhance performance overall The Guardian - UK · Jan 31, 2025
Cancer vaccine being created by UK scientists could stop disease up to 20 years early A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop The Independent UK · Jan 27, 2025
GSK and Oxford researchers to create cancer vaccine to stop disease developing GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines. Evening Standard · Jan 27, 2025
New cancer vaccine to stop disease before it takes hold in the body Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine The Independent UK · Jan 27, 2025
GSK signs £50m deal with Oxford University on cancer vaccines Collaboration over at least three years aims to help understand how pre-cancerous cells develop The Guardian - UK · Jan 27, 2025
Nvidia’s $465bn rout biggest in US stock market history, as DeepSeek sparks US tech sell-off – as it happened ECB president Lagarde warns of ‘vicious circle’ if central bank independence is undermined The Guardian - UK · Jan 27, 2025
Gina Torres reflects on role in ‘Suits’ reunion commercial during Super Bowl LVIII Actress Gina Torres reflects on her 'Suits' reunion commercial during Super Bowl LVIII w/ @EdEastonJr USA Today Sports Media Group · Jan 20, 2025
USA Today Sports Media Group · Jan 19, 2025 Brooke Shields on the impact of her ‘Friends’ appearance after Super Bowl XXX Chiefs Wire's @EdEastonJr spoke to iconic actress and author Brooke Shields at a women's empowerment brunch hosted by Donna Kelce.
The Guardian - UK · Jan 13, 2025 GSK to buy US cancer drug firm IDRx for up to $1.15bn Massachusetts-based company is working on new treatments for gastrointestinal cancers
Evening Standard · Jan 13, 2025 GSK buys US-based rare cancer treatment developer for up to £1bn The acquisition of IDRx will help GSK target a ‘major gap in the current standard of care’ related to gastrointestinal cancers.
The Guardian - UK · Jan 13, 2025 Pound slides to fresh 14-month low as stocks fall; rise in UK borrowing costs reverses – as it happened Dollar jumps to over two-year high against major currencies as bets on US rate cuts recede; UK 30-year government bond yield eases after hitting fresh 27-year high
Barchart · Dec 23, 2024 3 Pharma Stocks to Buy as California Sounds the Alarm on Bird Flu Cases The bird flu crisis is creating investment opportunities in the pharmaceutical sector, with Sanofi, GSK, and CSL Limited emerging as top picks.
MarketBeat · Dec 16, 2024 2 Small-Cap Stocks Set to Shine in a Bull Market Small-cap growth-orientated stocks like HTCR and CVAC often outperform during bullish markets due to their sensitivity to improving economic conditions.
The Guardian - UK · Nov 15, 2024 Pharma shares hit as Trump picks RFK Jr to lead health department Choice of vaccine critic knocks some of world’s biggest drugmakers including Moderna, AstraZeneca and GSK
Evening Standard · Nov 14, 2024 Men still outnumber women four to one at the top of the FTSE-100 career ladder Of the most senior full time jobs on the career ladder to chief executive, such as divisional or regional heads, only 21% are held by women.
Evening Standard · Oct 30, 2024 GSK sales hampered by slump in demand for key vaccine The drugmaker said sales of Arexvy fell sharply in the third quarter, but cancer and HIV treatments saw a stronger performance.
Evening Standard · Oct 30, 2024 FTSE 100 Live 30 October: Next forecasts £1bn profit, GSK vaccine sales weakness hits shares A £1 billion profits landmark for Next and strong trading at Standard Chartered today provided FTSE 100 cheer during another painful session for GSK investors.
Evening Standard · Oct 28, 2024 FTSE 100 Live 28 October: Oil price slide hits BP and Shell, Trainline upgrades guidance A 5% slide in the price of Brent Crude today ensured BP and Shell led the fallers board during an otherwise resilient session for the FTSE 100 index.